All nine patients treated with a personalized cancer vaccine following removal of their tumors remained cancer-free at a median data cut-off of 34.7 months.

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Annual Symposium held in San Francisco, CA between February 13–15, 2025 was host to a case-based session ...

Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at ...

There are currently 82,000 incident cases of RCC annually in the United States (account for 3–5% of cancers), with 15,000 deaths annually in the United States. The overall 5-year mortality risk is ~30 ...

The following is a summary of “Risk factors for renal insufficiency and survival implications after radical nephrectomy and ...

Patients with metastatic renal cell carcinoma staged pT1-4 Nx M1 were ... All patients had tumor nephrectomy or metastatic surgery at the University of Göttingen, Urology Department or at an ...

It feels like the Splinter Cell remake has been on its way for a while now, which isn't helped by the fact it's been over three years since we heard anything official about the game. From what we ...

Nephron-sparing surgery (NSS) for renal cell carcinoma has the advantage of ... into the inferior vena cava or renal vein, partial nephrectomy is not recommended Kidney damage due to warm ischemia ...

Clear cell renal cell carcinoma (ccRCC) is the most prevalent and lethal subtype ... the patient underwent cytoreductive nephrectomy (CN), metastasectomy, and targeted therapy. According to the ...

McDermott first revealed in 2021 that he had squamous cell carcinoma "several times." He added that he also has had basal cell cancer. According to the American Cancer Society, basal cell and ...

Background Laparoscopic radical nephrectomy (LRN) is the actual gold-standard for the treatment of clinically localized renal cell carcinoma (RCC) (cT1–2 with no indications for nephron-sparing ...